跳至主要内容
临床试验/CTRI/2025/03/083741
CTRI/2025/03/083741尚未招募不适用

A RANDOMIZED OPEN LABEL CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF PRATISARANA AGNIKARMA WITH MRUTTIKA SHALAKA IN THE MANAGEMENT OF GULPHASTHITHA SNAYUGATA VATA WITH SPECIAL REFERENCE TO ACHILLES TENDINITIS

Dr CHINNI VISHNU1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年4月21日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To see the significant reduction in pain, tenderness and improvement in range of movements of ankle joint.

研究概览

简要总结

THIS STUDY HAS BEEN TAKENUP TO EVALUATE THE EFFICACY OF PRATISARANA AGNIKARMA WITH  MRITTHIKA SHALAKA IN THE MANAGEMENT OF ACHILLES TENDINITIS

COMPARISION WITH BINDU AGNIKARMA WITH KSHAUDRA

RESEARCH QUESTION :

Whether Pratisarana Agnikarma with Mruttika Shalaka is effective in the management of Gulpha Sthitha Snayugata Vata with special reference to Achilles tendinitis?

NULL HYPOTHESIS –

H0     - There is no significant difference in efficacy of Pratisarana Agnikarma with Mruttika Shalaka and Bindu Agnikarma with Kshaudra in the management of Gupha Sthitha Snayugata Vata with special reference to Achilles tendinitis.

ALTERNATIVE HYPOTHESIS –

H1 -  Pratisarana Agnikarma with Mruttika Shalaka is more effective than Bindu Agnikarma with Kshaudra in the management of Gulpha Sthitha Snayugata Vata with special reference to Achilles tendinitis.

H2 –Bindu Agnikarma with Kshoudra is more effective than Pratisarana Agnikarma with Mruttika Shalaka in the management of Gulpha Sthitha Snayugata Vata with special reference to Achilles tendinitis.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects with age of 21 – 60 years irrespective of gender, religion, caste, race or socio-economic status and who are willing to give consent.
  • Subjects fulfilling the diagnostic criteria of Achilles tendinitis.

排除标准

  • Subjects suffering from diabetic neuropathy, foot drop.
  • Subjects with fracture of calcaneum & paget’s disease affecting calcaneum.
  • Subjects with rupture of Achilles tendon.
  • Subjects associated with sever systemic diseases and auto immune disorders will be excluded.
  • Subjects with foot related surgical history.

结局指标

主要结局

To see the significant reduction in pain, tenderness and improvement in range of movements of ankle joint.

时间窗: 0th day, 7th day, 14th day, 21st day

次要结局

  • To assess the significant improvement in the quality of life based on code AQoL-8D, SF-36, EQ-5D and VISA-A survey affected with Achilles tendinitis(reduced pain, swelling and range of motion of ankle affected with Achilles tendinitis)

研究者

发起方
Dr CHINNI VISHNU
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr CHINNI VISHNU

SRI SRI COLLEGE OF AYURVEDIC SCIENCE HOSPITAL AND RESEARCH

研究点 (1)

Loading locations...

相似试验